Animal Longevity Summit to debut in Toronto

The inaugural Animal Longevity Summit will bring aging researchers, veterinarians, biotech companies and investors to Toronto on Oct. 1-2, 2026. The meeting aims to advance cross-species longevity science by sharing new data on how aging in animals can be measured and slowed.

Why it matters: - The summit is meant to give animal longevity research a dedicated scientific home. - The event could speed translation of aging biology findings from animals into human healthspan research. - The focus on dogs and other animals puts practical, real-world evidence at the center of a fast-emerging field.

What happened: - The Animal Longevity Summit announced its inaugural two-day event for Oct. 1-2, 2026, in Toronto. - The summit will bring together researchers, geroscience-focused veterinarians, biotechnology companies and investors. - The meeting is built around the question of how aging biology can be measured, slowed and translated into longer, healthier lives, starting with animals.

The details: - The summit said the field is moving from theory toward real-world data. - Long-running efforts such as the Dog Aging Project and a growing number of veterinary clinical studies are generating early evidence on aging interventions in animals. - The program includes eight scientific tracks covering canine longevity and animal healthspan, comparative biology of aging, model and non-model organisms, biomarkers and aging clocks, interventions and therapeutics, veterinary geroscience, and cross-species translation to human health. - The format will include keynote talks, featured sessions and two postdoc research showcases selected from an open call for abstracts. - Confirmed speakers include Dr. Matt Kaeberlein of the Dog Aging Project, Dr. Vera Gorbunova of the University of Rochester, Dr. Aubrey de Grey of LEV Foundation, Dr. Varun Dwaraka of TruDiagnostic, Liz Parrish of BioViva, and Dr. Raghav Sehgal of Yale. - The full agenda will be released in the coming weeks. - Genflow Biosciences (LSE:GENF) said it will present data from its SLAB study of gene therapy in aged beagles at ALOS. - The summit's registration and program details are available at more information.

Between the lines: - The event reflects rising industry interest in aging science beyond humans. - ALOS is positioning itself as a bridge between veterinary science, biotechnology and longevity research. - The canine focus signals a push toward studies that are both scientifically relevant and more immediately measurable than some human longevity work.

What's next: - Organizers expect to announce the full agenda in the coming weeks. - More companies and research groups are likely to share data at the Toronto meeting. - The summit's first edition will test whether there is enough momentum to make animal longevity a durable conference category.

The bottom line: - ALOS is trying to turn animal aging research into a more organized, more collaborative field, with Toronto serving as the first major gathering point.